Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom

**Background:** Late-onset Pompe disease (LOPD) is a rare, progressive neuromuscular condition typically characterized by weakness of skeletal muscles, including those involved in respiration and diaphragmatic dysfunction. Individuals with LOPD typically eventually require mobility and/or ventilator...

Full description

Bibliographic Details
Main Authors: Lena Hubig, Anna-Katrine Sussex, Alasdair MacCulloch, Derralynn Hughes, Ryan Graham, Liz Morris, Syed Raza, Andrew J. Lloyd, Amanda Sowinski, Katy Gallop
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2023-03-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.68157
_version_ 1797341538786738176
author Lena Hubig
Anna-Katrine Sussex
Alasdair MacCulloch
Derralynn Hughes
Ryan Graham
Liz Morris
Syed Raza
Andrew J. Lloyd
Amanda Sowinski
Katy Gallop
author_facet Lena Hubig
Anna-Katrine Sussex
Alasdair MacCulloch
Derralynn Hughes
Ryan Graham
Liz Morris
Syed Raza
Andrew J. Lloyd
Amanda Sowinski
Katy Gallop
author_sort Lena Hubig
collection DOAJ
description **Background:** Late-onset Pompe disease (LOPD) is a rare, progressive neuromuscular condition typically characterized by weakness of skeletal muscles, including those involved in respiration and diaphragmatic dysfunction. Individuals with LOPD typically eventually require mobility and/or ventilatory support. **Objectives:** This study aimed to develop health state vignettes and estimate health state utility values for LOPD in the United Kingdom. **Methods:** Vignettes were developed for 7 health states of LOPD with states defined in terms of mobility and/or ventilatory support. Vignettes were drafted based on patient-reported outcome data from the Phase 3 PROPEL trial (NCT03729362) and supplemented by a literature review. Qualitative interviews with individuals living with LOPD and clinical experts were conducted to explore the health-related quality-of-life (HRQoL) impact of LOPD and to review the draft vignettes. Vignettes were finalized following a second round of interviews with individuals living with LOPD and used in health state valuation exercises with people of the UK population. Participants rated the health states using the EQ-5D-5L, visual analogue scale, and time trade-off interviews. **Results:** Twelve individuals living with LOPD and 2 clinical experts were interviewed. Following the interviews, 4 new statements were added regarding dependence on others, bladder control problems, balance issues/fear of falling, and frustration. One hundred interviews with a representative UK population sample were completed. Mean time trade-off utilities ranged from 0.754 (SD = 0.31) (no support) to 0.132 (SD = 0.50) (invasive ventilatory and mobility support–dependent). Similarly, EQ-5D-5L utilities ranged from 0.608 (SD = 0.12) to -0.078 (SD = 0.22). **Discussion:** The utilities obtained in the study are consistent with utilities reported in the literature (0.670-0.853 for nonsupport state). The vignette content was based on robust quantitative and qualitative evidence and captured the main HRQoL impacts of LOPD. The general public rated the health states consistently lower with increasing disease progression. There was greater uncertainty around utility estimates for the severe states, suggesting that participants found it harder to rate them. **Conclusion:** This study provides utility estimates for LOPD that can be used in economic modeling of treatments for LOPD. Our findings highlight the high disease burden of LOPD and reinforce the societal value of slowing disease progression.
first_indexed 2024-03-08T10:20:32Z
format Article
id doaj.art-4ae091c0a41040f2b24f13e0d0a1338a
institution Directory Open Access Journal
issn 2327-2236
language English
last_indexed 2024-03-08T10:20:32Z
publishDate 2023-03-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj.art-4ae091c0a41040f2b24f13e0d0a1338a2024-01-27T23:37:54ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362023-03-01101Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United KingdomLena HubigAnna-Katrine SussexAlasdair MacCullochDerralynn HughesRyan GrahamLiz MorrisSyed RazaAndrew J. LloydAmanda SowinskiKaty Gallop**Background:** Late-onset Pompe disease (LOPD) is a rare, progressive neuromuscular condition typically characterized by weakness of skeletal muscles, including those involved in respiration and diaphragmatic dysfunction. Individuals with LOPD typically eventually require mobility and/or ventilatory support. **Objectives:** This study aimed to develop health state vignettes and estimate health state utility values for LOPD in the United Kingdom. **Methods:** Vignettes were developed for 7 health states of LOPD with states defined in terms of mobility and/or ventilatory support. Vignettes were drafted based on patient-reported outcome data from the Phase 3 PROPEL trial (NCT03729362) and supplemented by a literature review. Qualitative interviews with individuals living with LOPD and clinical experts were conducted to explore the health-related quality-of-life (HRQoL) impact of LOPD and to review the draft vignettes. Vignettes were finalized following a second round of interviews with individuals living with LOPD and used in health state valuation exercises with people of the UK population. Participants rated the health states using the EQ-5D-5L, visual analogue scale, and time trade-off interviews. **Results:** Twelve individuals living with LOPD and 2 clinical experts were interviewed. Following the interviews, 4 new statements were added regarding dependence on others, bladder control problems, balance issues/fear of falling, and frustration. One hundred interviews with a representative UK population sample were completed. Mean time trade-off utilities ranged from 0.754 (SD = 0.31) (no support) to 0.132 (SD = 0.50) (invasive ventilatory and mobility support–dependent). Similarly, EQ-5D-5L utilities ranged from 0.608 (SD = 0.12) to -0.078 (SD = 0.22). **Discussion:** The utilities obtained in the study are consistent with utilities reported in the literature (0.670-0.853 for nonsupport state). The vignette content was based on robust quantitative and qualitative evidence and captured the main HRQoL impacts of LOPD. The general public rated the health states consistently lower with increasing disease progression. There was greater uncertainty around utility estimates for the severe states, suggesting that participants found it harder to rate them. **Conclusion:** This study provides utility estimates for LOPD that can be used in economic modeling of treatments for LOPD. Our findings highlight the high disease burden of LOPD and reinforce the societal value of slowing disease progression.https://doi.org/10.36469/001c.68157
spellingShingle Lena Hubig
Anna-Katrine Sussex
Alasdair MacCulloch
Derralynn Hughes
Ryan Graham
Liz Morris
Syed Raza
Andrew J. Lloyd
Amanda Sowinski
Katy Gallop
Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
Journal of Health Economics and Outcomes Research
title Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
title_full Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
title_fullStr Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
title_full_unstemmed Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
title_short Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
title_sort quality of life with late onset pompe disease qualitative interviews and general public utility estimation in the united kingdom
url https://doi.org/10.36469/001c.68157
work_keys_str_mv AT lenahubig qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT annakatrinesussex qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT alasdairmacculloch qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT derralynnhughes qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT ryangraham qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT lizmorris qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT syedraza qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT andrewjlloyd qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT amandasowinski qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom
AT katygallop qualityoflifewithlateonsetpompediseasequalitativeinterviewsandgeneralpublicutilityestimationintheunitedkingdom